Parexel and Palantir Technologies have unveiled an ambitious multi-year strategic partnership aimed at harnessing the power of artificial intelligence (AI) to elevate the delivery of clinical trials for Parexel's clientele. This collaboration sees Parexel integrating Palantir's Foundry and Artificial Intelligence Platform (AIP) into its clinical data platform, marking a significant leap forward in leveraging cutting-edge technology to enhance trial execution.
Elevating Clinical Trial Execution with AI
The partnership centers on enhancing Parexel's Precision Pathway, an end-to-end operational strategy that prioritizes the utilization of clean data in clinical trials. By leveraging Palantir's software, Precision Pathway will create an integrated digital environment to automate manual p
Parexel and Palantir Forge Deeper Partnership to Enhance Clinical Trials with AI
- By Anshika Mathews
- Published on
This collaboration sees Parexel integrating Palantir's Foundry and Artificial Intelligence Platform (AIP) into its clinical data platform, marking a significant leap forward in leveraging cutting-edge technology to enhance trial execution.
